STA R Max and Compact Max Coagulation Instruments
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- PANHCA25P0000006440
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- Place of performance
- Washington, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command, through the Medical Readiness Contracting Office - Pacific, has issued a Special Notice announcing its intent to award a sole-source delivery order to Diagnostica Stago Inc. of Parsippany, NJ for coagulation instruments. The award will be made under Federal Supply Schedule contract 36F797-18-D0351 using the authority of FAR 8.405-6(a)(1)(i)(B). The requirement encompasses STA R Max and Compact Max coagulation instruments along with associated reagents, consumables, and services for hemostatic testing at Madigan Army Medical Center. The contract structure includes a base period and three option periods, spanning from October 1, 2025 through September 30, 2029. This procurement supports blood clotting disorder monitoring and anticoagulant therapy assessment capabilities for military medical operations.
The sole-source justification is based on the unique technical requirement that the coagulation instruments must integrate with the government-owned Roche Cobas 8100 Total Laboratory Automation system, which only Diagnostica Stago's instruments can accomplish. While this notice is not a request for quotes and no solicitation will be issued, interested parties who believe they can provide equivalent capabilities may submit supporting documentation demonstrating their qualifications by September 17, 2025 at 11:00 AM Pacific Time. Contractors must provide clear and convincing evidence of their ability to satisfy the integration requirements and serve as authorized service providers for hemostasis product lines compatible with the existing laboratory automation system. A previous sources sought notice posted in June 2025 yielded no alternative sources, reinforcing the sole-source approach. All submitted documentation will be retained for potential use in future acquisitions, though no responses are expected to change the current procurement strategy.
Notice text
Medical Readiness Contracting Office - Pacific hereby provides notice of its intent to award a sole-source, firm fixed price delivery order using Federal Supply Schedule contract 36F797-18-D0351 under the authority of FAR 8.405-6(a)(1)(i)(B). As a result, the Government intends to award directly to Diagnostica Stago Inc.in Parsippany, NJ in accordance with FAR 8.405-6(a)(1)(i)(B), This requirement is expected to be delivery order with a base period and three (3) subsequent option periods.
This requirement is for coagulation instruments and the associated reagents, consumables and services for use in hemostatic testing to assess the effectiveness of anticoagulant therapy and monitor patients at risk of excessive bleeding. The STA R Max and Compact Max coagulation instruments from Diagnostica Stago, Inc. (DSI) are the only instruments that can connect to and integrate with the government owned Cobas 8100 TLA system manufactured by Roche. DSI is the exclusive provider of their hemostasis product lines in the United States that can integrate between the Cobas 8100 TLA and the STA R Max and Compact Max coagulation systems. Therefore, DSI is the only business available to provide these supplies as an authorized service provider. The attached Limited Source Justification detail the requirements of this anticipated contract action.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR QUOTES; no solicitation or RFQ will be forthcoming.
Any firm that believes it can provide the stated supplies can provide supporting documents demonstrating their capabilities and certifications. Interested parties may identify their interest and capability to respond to this requirement no later than Wednesday, 17 September 2025 at 11:00 AM Pacific Time.
All documents submitted will not be returned. Responses received may be used for future acquisitions. All interested parties shall submit clear and convincing documentation demonstrating their capabilities to satisfy the requirements contained within the attached Statement of Work. The capability documentation should include general information and technical background describing in detail the prospective contractor's capabilities and experience that will demonstrate the ability to support these requirements.
Interested parties are encouraged to furnish information by email only with subject line stating - RESPONSE TO INTENT TO SOLE SOURCE FOR PANHCA25P0000006440. Information can be sent to Brittany Chartier at brittany.n.chartier.civ@health.mil. No telephone or facsimile requests will be accepted. This procurement will be prepared in accordance with FAR Part 8, Federal Supply Schedule.
Medical Readiness Contracting Office - Pacific will NOT be responsible for any costs incurred by interested parties in responding to this notice of intent. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Files
| File | Type | Posted |
|---|---|---|
| LSJ FAR 8 STA R Max Coagulation_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| STA R Max and Compact Max Coagulation Instruments | Award Notice | |
| This notice | Special Notice | |
| Reagents Madigan Military Treatment Facility | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Award Maintenance for Government owned BacT/ALERT 3D Equipment. | Medical Command | No set-aside | |
| Siemens UniPOC License Sole-Source | Defense Health Agency | No set-aside | |
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside | |
| 6550--VISN 4 Coagulation Testing | Veterans Integrated Service Network 4 | No set-aside | |
| 6550--Notice of Intent to Sole-Source T-SPOT. TB® Reagents and Kits | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity